Janus Henderson Group
VRDN icon

Janus Henderson Group’s Viridian Therapeutics VRDN Stock Holding History

Janus Henderson Group’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$537K Hold
27,472
– – ﹤0.01% 1981
2025
Q4 		$854K Hold
27,472
– – ﹤0.01% 1753
2025
Q3 		$593K Hold
27,472
– – ﹤0.01% 1925
2025
Q2 		$384K Hold
27,472
– – ﹤0.01% 2075
2025
Q1 		$397K Hold
27,472
– – ﹤0.01% 2076
2024
Q4 		$526K Hold
27,472
– – ﹤0.01% 2006
2024
Q3 		$625K Hold
27,472
– – ﹤0.01% 1924
2024
Q2 		$357K Buy
27,472
+14,051
+105% +$195K ﹤0.01% 2126
2024
Q1 		$235K Buy
13,421
+57
+0.4% +$1.1K ﹤0.01% 2344
2023
Q4 		$291K Sell
13,364
-31
-0.2% -$489 ﹤0.01% 2249
2023
Q3 		$206K Buy
13,395
+9
+0.1% +$172 ﹤0.01% 2371
2023
Q2 		$318K Sell
13,386
-28
-0.2% -$718 ﹤0.01% 2218
2023
Q1 		$341K Buy
+13,414
New +$430K ﹤0.01% 2222

Other funds holding VRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return